Fintepla® (fenfluramine) oral solution is a prescription medication approved by the fda and authorized by the eu commission, and under regulatory review with the pmda (japan), for the treatment of seizures associated with dravet syndrome in patients two years of age and older.8,12 a type ii variation application has also been submitted to the. See boxed warning, prescribing information, and medication guide. Learn about fintepla®, a treatment for seizures associated with dravet syndrome and lgs, and get full prescribing information, including boxed warning. Fintepla package insert / prescribing information for healthcare professionals Indications, dosage, adverse reactions and pharmacology. Fintepla® (fenfluramine) oral solution is a prescription medication approved by the fda and ema, and under regulatory review with pmda (japan), for the treatment of seizures associated with dravet syndrome in patients two years of age and older
10,11 a type ii variation application for treatment of seizures associated with lgs has also been. On june 25, 2020, fen was approved by the fda as fintepla for the treatment of seizures associated with ds in patients 2 years of age and older.
WATCH